172 followers
Quant. benefit–risk assessment of methylprednisolone in MS relapses https://t.co/Wutp30czi9
Quant. benefit–risk assessment of methylprednisolone in MS relapses https://t.co/Wutp30czi9
RT @UMCGlobalSafety: Read "Quant. beneft—risk assessmnt of methylprednisolone in #MS relapses" by @OlaCaster & Edwards in @BioMedCentral: h…
Read "Quant. beneft—risk assessmnt of methylprednisolone in #MS relapses" by @OlaCaster & Edwards in @BioMedCentral: https://t.co/urKio3TXKK
Read @OlaCaster & Edward's "Quantitative benefit-risk asst of #methylprednisolone in #MS relapses" in #BMCNeurology: https://t.co/NDOYQDt0Ib